S&P 500   2,995.03 (-0.03%)
DOW   26,754.85 (-0.12%)
QQQ   191.56 (-0.15%)
AAPL   242.28 (+0.97%)
FB   184.88 (+1.39%)
MSFT   136.17 (-0.15%)
GOOGL   1,252.74 (+0.93%)
AMZN   1,756.90 (-0.50%)
CGC   21.69 (+2.55%)
NVDA   192.94 (-1.36%)
MU   44.51 (-0.34%)
BABA   168.68 (-0.71%)
GE   9.07 (+0.00%)
AMD   31.21 (-0.95%)
T   37.69 (-1.26%)
F   9.10 (+0.33%)
ACB   3.67 (+2.51%)
NFLX   270.34 (+1.37%)
GILD   66.47 (+0.93%)
DIS   131.21 (-0.90%)
S&P 500   2,995.03 (-0.03%)
DOW   26,754.85 (-0.12%)
QQQ   191.56 (-0.15%)
AAPL   242.28 (+0.97%)
FB   184.88 (+1.39%)
MSFT   136.17 (-0.15%)
GOOGL   1,252.74 (+0.93%)
AMZN   1,756.90 (-0.50%)
CGC   21.69 (+2.55%)
NVDA   192.94 (-1.36%)
MU   44.51 (-0.34%)
BABA   168.68 (-0.71%)
GE   9.07 (+0.00%)
AMD   31.21 (-0.95%)
T   37.69 (-1.26%)
F   9.10 (+0.33%)
ACB   3.67 (+2.51%)
NFLX   270.34 (+1.37%)
GILD   66.47 (+0.93%)
DIS   131.21 (-0.90%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Endo InternationalTherapeuticsMDCara TherapeuticsOmerosOdonate Therapeutics
SymbolNASDAQ:ENDPNASDAQ:TXMDNASDAQ:CARANASDAQ:OMERNASDAQ:ODT
Price Information
Current Price$4.72$3.68$19.63$15.46$30.44
52 Week RangeHoldBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price Target$7.58$10.00$26.93$27.75N/A
% Upside from Price Target60.49% upside171.74% upside37.18% upside79.50% upsideN/A
Trade Information
Market Cap$1.05 billion$916.64 million$778.34 million$773.36 million$931.92 million
Beta1.331.692.222.841.77
Average Volume10,266,2342,901,691585,272349,221104,828
Sales & Book Value
Annual Revenue$2.95 billion$16.10 million$13.47 million$29.87 millionN/A
Price / Sales0.3655.1458.3425.51N/A
Cashflow$6.38 per shareN/AN/AN/AN/A
Price / Cash0.74N/AN/AN/AN/A
Book Value($2.22) per share$0.41 per share$3.38 per share($2.04) per share$4.62 per share
Price / Book-2.138.985.81-7.58N/A
Profitability
Net Income$-1,031,470,000.00$-132,620,000.00$-74,010,000.00$-126,760,000.00$-88,960,000.00
EPS$2.89($0.59)($2.06)($2.22)($3.64)
Trailing P/E Ratio1.63N/AN/AN/AN/A
Forward P/E Ratio2.02N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-19.98%-913.07%-420.97%-135.46%N/A
Return on Equity (ROE)-129.30%-212.57%-68.36%N/A-78.04%
Return on Assets (ROA)5.75%-72.82%-46.96%-94.78%-68.36%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A24.29%0.04%N/AN/A
Current Ratio1.50%5.17%3.11%1.62%9.61%
Quick Ratio1.32%4.99%3.11%1.59%9.61%
Ownership Information
Institutional Ownership Percentage95.78%78.00%64.92%53.13%96.52%
Insider Ownership Percentage1.50%18.91%5.80%12.80%59.30%
Miscellaneous
Employees2,91024155236117
Shares Outstanding226.39 million241.22 million40.03 million49.29 million32.19 million
Next Earnings Date11/5/2019 (Confirmed)11/6/2019 (Estimated)11/5/2019 (Estimated)11/14/2019 (Estimated)10/28/2019 (Estimated)
OptionableOptionableOptionableOptionableOptionableNot Optionable
 Endo InternationalTherapeuticsMDCara TherapeuticsOmerosOdonate Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel